Celiac disease in patients with type 1 diabetes: A condition with distinct changes in intestinal immunity?

Cellular and Molecular Immunology

Volumn 8, Issue 2, 2011, Pages 150-156

  Uibo, Raivo ^a   Panarina, Marina ^a   Teesalu, Kaupo ^a   Talja, Ija ^a   Sepp, Epp ^a   Utt, Meeme ^a   Mikelsaar, Marika ^a   Heilman, Kaire ^b   Uibo, Oivi ^a,b   Vorobjova, Tamara ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

autoimmunity; celiac disease; immunoregulation; intestinal mucosa; type 1 diabetes

Indexed keywords

BACTERIAL PROTEIN; BETA LACTOGLOBULIN; DEAMIDATED GLIADIN; GLIADIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN ZO1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BIFIDOBACTERIUM ADOLESCENTIS; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; MUCOSAL IMMUNITY; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SMALL INTESTINE MUCOSA;

ADOLESCENT; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BIFIDOBACTERIUM; CATTLE; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLIADIN; GTP-BINDING PROTEINS; HUMANS; IMMUNITY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; INTESTINAL MUCOSA; INTESTINES; LACTOGLOBULINS; MALE; MEMBRANE PROTEINS; PHOSPHOPROTEINS; RNA, MESSENGER; TRANSGLUTAMINASES;

BIFIDOBACTERIUM ADOLESCENTIS; BOVINAE;

EID: 79952392090     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.66     Document Type: Article

References (51)

1. Green PH, Cellier C Celiac disease. N Engl J Med 2007; 357: 1731-1743.
2. Franzese A, Lombardi F, Valerio G, Spagnuolo A. Updateoncoeliacdiseaseandtype 1 diabetes mellitus in children. J Ped Endocrinol Metab 2007; 20: 1257-1264.
3. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767-2777.
4. Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity. Celiac disease and type 1 diabetes paradigms. Ann NY Acad Sci 2009; 1165: 195-205.
5. Lefebvre DE, Powell KC, Strom A, Scott FW. Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Ann Rev Nutr 2006; 26: 175-202.
6. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp S L et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 2010; 42:530-538.
7. Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010; 9: A355-A365.
8. Kondrashova A, Mustalahti K, Kaukinen K, Viskari H, Volodicheva V, Haapala AM et al. Lower economic status and inferior hygiene environment may protect against celiac disease. Ann Med 2008; 40: 223-231. (Pubitemid 351482545)
9. Ress K, Harro M, Maaroos HI, Harro J, Uibo R, Uibo O. High prevalenceof celiacdisease: need for increasing awareness among physicians. Dig Liv Dis 2007; 39: 136-139. (Pubitemid 46117924)
10. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 2009; 9: 858-870.
11. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptideantibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010; 31: 73-81.
12. Marsh MN, Crowe PT. Morphologyof themucosal lesion inglutensensitivity. Bailleres Clin Gastroenterol 1995; 9: 273-293.
13. Tiittanen M, Westerholm-Ormio M, Verkasalo M, Savilahti E, Vaarala O. Infiltration of forkheadboxP3-expressingcells insmall intestinal mucosa incoeliacdiseasebut not in type 1 diabetes. Clin Exp Immunol 2008; 152: 498-507. (Pubitemid 351661513)
14. Vorobjova T, Uibo O, Heilman K, RägoT, Honkanen J, Vaarala O et al. Increased FOXP3 expression insmall-bowel mucosaof childrenwithcoeliacdiseaseandtype 1 diabetes mellitus. Scand J Gastroenterol 2009; 44: 422-430.
15. Westerholm-Ormio M, Vaarala O, Tittanen M, Savilahti E. Infiltration of Foxp3-and To ll-l i ke receptor-4-positive cells in the intestines of children with food allergy. J Pediatr Gastroenterol Nutr 2010; 50: 367-376.
16. Skovbjerg H, Hansen GH, Niels-Christiansen LL, Anthonsen D, Ascher H, Midhagen G et al. Intestinal tissue transglutaminase in coeliac disease of children and adults: ultrastructural localization andvariation in expression. Scand J Gastroenterol 2004; 39:1219-1227. (Pubitemid 39656837)
17. Pinkas DM. Strop P, Brunger AT, Khosla C Transglutaminase 2 undergoes a large conformational change upon activation. Plo S Biol 2007; 5: e327.
18. Sartor RB. Microbial influences in inflammatory bowel disease. Gastroenterology 2008; 134: 577-594. (Pubitemid 351173057)
19. Ménard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010; 3: 247-259.
20. Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K et al. Gliadin induces an increase in intestinal permeability and zonulin release by bindingto the chemokine receptor CXCR3. Gastroenterology 2008; 135: 194-204.
21. Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M. Epithelial tightjunction structure in the jejunum of children with acuteand treated celiac sprue. Pediatr Res 1998; 43: 435-441. (Pubitemid 28157949)
22. Secondulfo M, Iafusco D, Carratù R, deMagistris L, Sapone A, Generoso M et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-coeliac, type 1 diabetic patients. Dig Liv Dis 2004; 36: 35-45. (Pubitemid 41122223)
23. Bosi E, Molteni L, Radaelli MG, Folini L, Fermo L, Bazzigaluppi E et al. Increased intestinal permeability preceded clinical onset of type 1 diabetes. Diabetologia 2006; 49:2824-2827. (Pubitemid 44730283)
24. Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006; 55: 1443-1449. (Pubitemid 44195385)
25. Neu J, Reverte M, Mackey AD, Liboni K, Tuhacek-Tenace LM, Hatch M et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 2005; 40: 589-595. (Pubitemid 40617187)
26. Watts T, Berti I, Sapone A, Gerarduzzi T, Not T, Zielke R et al. Role of the intestinal tightjunction modulatorzonulin inthepathogenesisof type 1 diabetes in B Bdiabetic-prone rats. Proc Natl Acad Sci USA 2005; 102: 2916-2921. (Pubitemid 40299891)
27. Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gutbarrierdisruptionby an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 2010; 53:741-748.
28. Ou G, Hedberg M, Hörstedt P, Baranov V, Forsberg G, Drobni M et al. Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol 2009; 104: 3058-3067.
29. Prangli AL, Utt M, Talja I, Sepp E, Mikelsaar M, Rajasalu T et al. An immunoblotassay for determination of Ig G antibodies against lactobacilli representing human indigenous microflora. Pediatr Allergy Immunol 2010; 21: e772-e779.
30. Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G et al. Toward definingtheautoimmune microbiome for type 1 diabetes. ISME J2010; 5: 82-91.
31. Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, Spencely K et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 2004;11:686-690. (Pubitemid 38943990)
32. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001; 30: 43-47. (Pubitemid 32145003)
33. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium spp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 2007; 51: 260-269. (Pubitemid 47547504)
34. Vaarala O, Atkinson M, Neu J. The "perfect storm" for type 1 diabetes. The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 10: 2555-2562.
35. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55:1512-1520. (Pubitemid 44476799)
36. Uibo O, Heilman K, Rägo T, Shor R, Paal M, Metsküla K et al. Symptomless coeliac disease in type I diabetes: 12-yearexperience in Estonia. Pediatr Int 2010; 52: 230-233.
37. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992; 102: 330-354.
38. Green PH, Rostami K, Marsh MN. Diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19: 389-400. (Pubitemid 40753760)
39. Walker-Smith J, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of celiac disease. Report of working group of European Society of Pediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-911.
40. Teesalu K, Agardh D, Panarina M, Utt M, Uibo O, Uibo R. A modified ELISA for improved detection of Ig A, Ig G, Ig M anti-tissue transglutaminase antibodies in celiac disease. Clin Chim Acta 2009; 403: 37-41.
41. Nilsson I, Kornilovs'ka I, Lindgren S, Ljungh A, Wadström T. Increased prevalenceof seropositivityfor non-gastric Helicobacterspecies in patientswith autoimmune liver disease. J Med Microbiol 2003: 52: 949-953. (Pubitemid 38648133)
42. Király R, Vecsei Z, Deményi T, Korponay-Szabó IR, Fésüs L. Coeliac autoantibodies can enhance transamidatingand inhibit G T Pase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness. J Autoimmun 2006; 26: 278-287. (Pubitemid 43817486)
43. Sambuy Y, deAngelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2cell lineasa modelof theintestinal barrier: influenceof cellandculture-relatedfactorson Caco-2 cell functional characteristics. Cell Biol Toxicol 2005; 21: 1-26.
44. Cronin CC, Shanafan F. Insulin-dependent diabetes mellitus and coeliac disease. Lancet 1997; 349: 1096-1097. (Pubitemid 27158264)
45. Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002; 109: 833-838. (Pubitemid 34493349)
46. Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochim Biophys Acta 2009; 1788:832-841.
47. Laparra JM, Sanz Y. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem 2010; 109: 801-807.
48. Barnes RM, Harvey MM, Blears J, Finn R, Johnson PM. Ig G subclassof human serum antibodies reactive with dietary proteins. Int Arch Allergy Appl Immunol 1986; 81: 141-147. (Pubitemid 16015114)
49. Savilahti E, Saukkonen TT, Virtala ET, Tuomilehto J, Kerblom HK. The Childhood Diabetes in Finland Study Group. Increased levels of cow's milk and β-lactoglobulin antibodies in young children with newly diagnosed IDDM. Diabetes Care 1993; 16: 984-989. (Pubitemid 23184528)
50. Simpson M, Mojibian M, Barriga K, Scott FW, Fasano A, Rewers M et al. Anexploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes 2009; 10: 563-572.
51. Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000; 355: 1518-1519. (Pubitemid 30237361)